Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
$60.32
+3.1%
$48.48
$19.01
$60.48
$11.34B1.713.03 million shs2.05 million shs
Celcuity, Inc. stock logo
CELC
Celcuity
$134.26
-2.9%
$121.96
$10.26
$151.02
$6.74B0.091.18 million shs687,484 shs
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$21.59
-0.2%
$22.37
$20.02
$29.71
$12.09B0.81834,454 shs677,457 shs
Guardant Health, Inc. stock logo
GH
Guardant Health
$119.85
+0.8%
$92.53
$37.73
$121.01
$15.77B1.482.17 million shs1.98 million shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
0.00%+4.13%+21.47%+45.16%+151.83%
Celcuity, Inc. stock logo
CELC
Celcuity
0.00%+4.58%+14.21%+30.66%+1,224.04%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
0.00%-2.43%-4.70%-4.47%-25.11%
Guardant Health, Inc. stock logo
GH
Guardant Health
0.00%+24.35%+33.79%+24.69%+213.03%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
$60.32
+3.1%
$48.48
$19.01
$60.48
$11.34B1.713.03 million shs2.05 million shs
Celcuity, Inc. stock logo
CELC
Celcuity
$134.26
-2.9%
$121.96
$10.26
$151.02
$6.74B0.091.18 million shs687,484 shs
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$21.59
-0.2%
$22.37
$20.02
$29.71
$12.09B0.81834,454 shs677,457 shs
Guardant Health, Inc. stock logo
GH
Guardant Health
$119.85
+0.8%
$92.53
$37.73
$121.01
$15.77B1.482.17 million shs1.98 million shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
0.00%+4.13%+21.47%+45.16%+151.83%
Celcuity, Inc. stock logo
CELC
Celcuity
0.00%+4.58%+14.21%+30.66%+1,224.04%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
0.00%-2.43%-4.70%-4.47%-25.11%
Guardant Health, Inc. stock logo
GH
Guardant Health
0.00%+24.35%+33.79%+24.69%+213.03%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
3.12
Buy$57.00-5.50% Downside
Celcuity, Inc. stock logo
CELC
Celcuity
2.83
Moderate Buy$149.3011.20% Upside
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
1.56
Reduce$28.0029.69% Upside
Guardant Health, Inc. stock logo
GH
Guardant Health
2.86
Moderate Buy$129.538.07% Upside

Current Analyst Ratings Breakdown

Latest CELC, GH, FMS, and BTSG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/26/2026
Guardant Health, Inc. stock logo
GH
Guardant Health
Boost Price TargetBuy$145.00 ➝ $155.00
5/21/2026
Guardant Health, Inc. stock logo
GH
Guardant Health
Set Price Target$127.00
5/21/2026
Guardant Health, Inc. stock logo
GH
Guardant Health
Reiterated RatingBuy
5/21/2026
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
Set Price Target$70.00
5/19/2026
Celcuity, Inc. stock logo
CELC
Celcuity
DowngradeSell (D-)Sell (E+)
5/18/2026
Celcuity, Inc. stock logo
CELC
Celcuity
Boost Price TargetBuy$165.00 ➝ $185.00
5/15/2026
Celcuity, Inc. stock logo
CELC
Celcuity
Boost Price TargetOverweight$150.00 ➝ $183.00
5/15/2026
Celcuity, Inc. stock logo
CELC
Celcuity
Reiterated RatingBuy$157.00
5/12/2026
Guardant Health, Inc. stock logo
GH
Guardant Health
Reiterated RatingOverweight$135.00
5/8/2026
Guardant Health, Inc. stock logo
GH
Guardant Health
Boost Price TargetOverweight$115.00 ➝ $120.00
5/8/2026
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
UpgradeStrong SellModerate Sell
(Data available from 5/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
$12.91B0.91$2.27 per share26.62$10.21 per share5.91
Celcuity, Inc. stock logo
CELC
Celcuity
N/AN/AN/AN/A$1.10 per shareN/A
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$22.20B0.54$5.55 per share3.89$29.76 per share0.73
Guardant Health, Inc. stock logo
GH
Guardant Health
$982.02M16.18N/AN/A($1.37) per share-87.48
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
$190.67M$1.4142.7830.310.772.27%14.63%4.41%7/31/2026 (Estimated)
Celcuity, Inc. stock logo
CELC
Celcuity
-$177.04M-$3.90N/A3,356.50N/AN/A-244.61%-50.22%8/13/2026 (Estimated)
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$1.11B$1.9011.368.883.904.88%8.90%4.05%8/4/2026 (Estimated)
Guardant Health, Inc. stock logo
GH
Guardant Health
-$416.28M-$3.39N/AN/AN/A-40.10%N/A-26.42%7/29/2026 (Estimated)

Latest CELC, GH, FMS, and BTSG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2026Q1 2026
Celcuity, Inc. stock logo
CELC
Celcuity
-$1.07-$0.97+$0.10-$0.97$2.94 millionN/A
5/5/2026Q1 2026
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$0.59$0.53-$0.06$0.25$5.41 billion$5.34 billion
5/1/2026Q1 2026
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
$0.29$0.39+$0.10$0.67$3.39 billion$3.61 billion
3/31/2026Q1 2026
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
N/A$1.0530N/A$0.25N/A$5.34 billion
3/25/2026Q4 2025
Celcuity, Inc. stock logo
CELC
Celcuity
-$1.06-$0.97+$0.09-$0.97$1.28 millionN/A
2/27/2026Q4 2025
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
$0.34$0.33-$0.01$0.35$3.38 billion$3.55 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
N/AN/AN/AN/AN/A
Celcuity, Inc. stock logo
CELC
Celcuity
N/AN/AN/AN/AN/A
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$0.612.83%+2.66%32.11%N/A
Guardant Health, Inc. stock logo
GH
Guardant Health
N/AN/AN/AN/AN/A

Latest CELC, GH, FMS, and BTSG Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/1/2026
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
annual$0.87164.02%5/22/20265/22/20266/8/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
1.24
1.74
1.38
Celcuity, Inc. stock logo
CELC
Celcuity
6.04
12.31
12.31
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
0.40
1.20
0.86
Guardant Health, Inc. stock logo
GH
Guardant Health
N/A
4.68
4.39
CompanyEmployeesShares OutstandingFree FloatOptionable
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
23,500193.92 million188.49 millionOptionable
Celcuity, Inc. stock logo
CELC
Celcuity
4048.77 million42.27 millionOptionable
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
1,488558.58 millionN/AOptionable
Guardant Health, Inc. stock logo
GH
Guardant Health
2,506132.60 million125.17 millionNot Optionable

Recent News About These Companies

John Saia Sells 20,000 Shares of Guardant Health (NASDAQ:GH) Stock
Ian Clark Sells 6,876 Shares of Guardant Health (NASDAQ:GH) Stock
Why Guardant Health (GH) Stock Is Down Today

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
BrightSpring Health Services stock logo

BrightSpring Health Services NASDAQ:BTSG

$60.32 +1.82 (+3.11%)
As of 04:00 PM Eastern

BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.

Celcuity stock logo

Celcuity NASDAQ:CELC

$134.26 -3.97 (-2.87%)
As of 04:00 PM Eastern

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.

Fresenius Medical Care AG & Co. KGaA stock logo

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

$21.59 -0.05 (-0.23%)
As of 03:58 PM Eastern

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Guardant Health stock logo

Guardant Health NASDAQ:GH

$119.85 +0.90 (+0.76%)
As of 04:00 PM Eastern

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.